Under new leadership, Novartis' Sandoz unit breaks up with digital therapeutics outfit Pear
Looks like Novartis’ Sandoz unit — under new leadership — has severed ties with Pear Therapeutics, dissolving the partnership that was inked in 2018.
Last year, Sandoz …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.